Clinical Trial: A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)

U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT06908226) titled 'A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)' on March 06.

Brief Summary: This (DEEp OLE Study) is a multicentre, open-label study to investigate the long-term safety, efficacy, tolerability, and pharmacokinetics (PK) of LP352 in the treatment of seizures in children and adults with DEE who completed Study LP352-301 or LP352-302. The study consists of 3 main phases: Screening, Titration period and Maintenance period, followed by a Taper period and Follow-Up. The total duration of the study will be approximately 14 months.

Study Start Date: Feb. 12

Study Type: INTERVENTIO...